| Advantages | They reconstitute key hepatic functions such as urea cycling, carbohydrate/lipid metabolism, and xenobiotic metabolism. Research applications include studying ruminant liver pathophysiology, monitoring antibiotic and veterinary drug residues, and evaluating nutrition-related metabolism and production traits. |
| Species | Bovine |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Liver |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | All batches undergo testing for mycoplasma, bacteria, and fungi, and are confirmed for identity and genetic stability via lineage markers, species-specific PCR/STR, and karyotype/sequencing. Release criteria include functional metrics such as albumin secretion, urea production, and CYP induction. |
| Applications | Tissue-derived organoids are extensively used in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By faithfully recapitulating disease states, they provide a robust platform for assessing patient-specific responses to investigational drugs and facilitating personalized treatment strategies. In addition, these organoids drive the development of novel therapeutic approaches, particularly in cancer biology and tissue regeneration, offering precise experimental tools that enhance progress in precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.